Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7183)
All Articles published online
|
Publishing Process of This Article
|
Nov 8, 2015 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rahimlou M, Ahmadnia H, Hekmatdoost A. Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the future. World J Hepatol 2015; 7(25): 2597-2602 [PMID: 26557952 DOI: 10.4254/wjh.v7.i25.2597] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i25/2597.htm |
| Number | Citing Articles |
| 1 |
Ali Amirinejad, Azita Hekmatdoost, Abdolali Ebrahimi, Fatemeh Ranjbaran, Farzad Shidfar. The effects of hydroalcoholic extract of spinach on prevention and treatment of some metabolic and histologic features in a rat model of nonalcoholic fatty liver disease. Journal of the Science of Food and Agriculture 2020; 100(4): 1787 doi: 10.1002/jsfa.10215
|
| 2 |
Asieh Mansour, Azita Hekmatdoost, Parvin Mirmiran. What are the main areas of focus to prevent or treat non‐alcoholic fatty liver disease?. Journal of Digestive Diseases 2019; 20(6): 271 doi: 10.1111/1751-2980.12751
|
| 3 |
Xenophon Theodoridis, Georgios Kalopitas, Andreas Vadarlis, Dimitra Rafailia Bakaloudi, Νikolaos Gkiourtzis, Georgios Dionysopoulos, Evangelia Karanika, Eirini Tsekitsidi, Michail Chourdakis. Comparative efficacy of different treatment modalities in the management of pediatric non-alcoholic fatty liver disease: A systematic review and network meta-analysis. Pharmacology & Therapeutics 2022; 240: 108294 doi: 10.1016/j.pharmthera.2022.108294
|
| 4 |
Vahid Kheirandish, Maysam Mard-Soltani, Faraz Mojab, Neda Shakerian, Farhad Nanaie. The Effect of Milk Thistle, Green Tea, and Cinnamon Beverages on Liver Enzymes of Operating Room Anesthesia Personnel. Trends in Medical Sciences 2023; 3(1) doi: 10.5812/tms-136000
|
| 5 |
Makan Cheraghpour, Hossein Imani, Shahrzad Ommi, Seyed Moayed Alavian, Elahe Karimi‐Shahrbabak, Mehdi Hedayati, Zahra Yari, Azita Hekmatdoost. Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial. Phytotherapy Research 2019; 33(8): 2118 doi: 10.1002/ptr.6406
|
| 6 |
Abbas Ali Sangouni, Zahra Orang, Hassan Mozaffari-Khosravi. Effect of omega-3 supplementation on fatty liver and visceral adiposity indices in diabetic patients with non-alcoholic fatty liver disease: A randomized controlled trial. Clinical Nutrition ESPEN 2021; 44: 130 doi: 10.1016/j.clnesp.2021.06.015
|
| 7 |
Fariba Aghaei, Alexei Wong, Mehdi Zargani, Amir Sarshin, Foad Feizolahi, Zhila Derakhshan, Mohammadreza Hashemi, Ehsan Arabzadeh. Effects of swimming exercise combined with silymarin and vitamin C supplementation on hepatic inflammation, oxidative stress, and histopathology in elderly rats with high-fat diet-induced liver damage. Nutrition 2023; 115: 112167 doi: 10.1016/j.nut.2023.112167
|
| 8 |
Annalisa Crudele, Nadia Panera, Maria Rita Braghini, Clara Balsano, Anna Alisi. The pharmacological treatment of nonalcoholic fatty liver disease in children. Expert Review of Clinical Pharmacology 2020; 13(11): 1219 doi: 10.1080/17512433.2020.1829468
|
| 9 |
Shunming Zhang, Yeqing Gu, Shanshan Bian, Magdalena J. Górska, Qing Zhang, Li Liu, Ge Meng, Zhanxin Yao, Hongmei Wu, Yawen Wang, Tingjing Zhang, Xuena Wang, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Lu Qi, Kaijun Niu. Dietary patterns and risk of non-alcoholic fatty liver disease in adults: A prospective cohort study. Clinical Nutrition 2021; 40(10): 5373 doi: 10.1016/j.clnu.2021.08.021
|
| 10 |
Aanchal Gupta, Shajith Anoop, Irshad Ahmad Ansari, Satya Prakash, Anoop Misra. High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus. Clinical Nutrition ESPEN 2021; 46: 519 doi: 10.1016/j.clnesp.2021.08.028
|
| 11 |
Emma T. Saltzman, Talia Palacios, Michael Thomsen, Luis Vitetta. Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00061
|
| 12 |
Kun-Ping Li, Yang Yu, Min Yuan, Chu-Mei Zhang, Xiang-Lu Rong, Jeremy E. Turnbull, Jiao Guo, Mohammad H.osein Ayati. Tian-Huang Formula, a Traditional Chinese Medicinal Prescription, Improves Hepatosteatosis and Glucose Intolerance Targeting AKT-SREBP Nexus in Diet-Induced Obese Rats. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/6617586
|
| 13 |
Anastasios Serbis, Stergios A. Polyzos, Stavroula A. Paschou, Ekaterini Siomou, Dimitrios N. Kiortsis. Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?. Endocrine 2024; doi: 10.1007/s12020-024-03783-7
|
| 14 |
Hadi Emamat, Forough Foroughi, Hassan Eini–Zinab, Mohsen Taghizadeh, Marjan Rismanchi, Azita Hekmatdoost. The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease. Journal of Diabetes & Metabolic Disorders 2015; 15(1) doi: 10.1186/s40200-016-0248-4
|
| 15 |
Saeede Saadati, Amir Sadeghi, Asieh Mansour, Zahra Yari, Hossein Poustchi, Mehdi Hedayati, Behzad Hatami, Azita Hekmatdoost. Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1055-4
|
| 16 |
Chiara Spiezia, Claudia Di Rosa, Danilo Fintini, Pietro Ferrara, Laura De Gara, Yeganeh Manon Khazrai. Nutritional Approaches in Children with Overweight or Obesity and Hepatic Steatosis. Nutrients 2023; 15(11): 2435 doi: 10.3390/nu15112435
|
| 17 |
Abbas Ali Sangouni, Zohreh Sadat Sangsefidi, Faezeh Yarhosseini, Mahdieh Hosseinzadeh, Mohsen Akhondi-Meybodi, Alimohammad Ranjbar, Farzan Madadizadeh, Hassan Mozaffari-Khosravi. Effect of Cornus mas L. fruit extract on lipid accumulation product and cardiovascular indices in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled trial. Clinical Nutrition ESPEN 2022; 47: 51 doi: 10.1016/j.clnesp.2021.11.023
|
| 18 |
Satya Priya Sharma, Ki Tae Suk, Dong Joon Kim. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases. World Journal of Gastroenterology 2021; 27(37): 6161-6179 doi: 10.3748/wjg.v27.i37.6161
|
| 19 |
Arianna Solito, Nicole Bozzi Cionci, Matteo Calgaro, Marina Caputo, Lucia Vannini, Iderina Hasballa, Francesca Archero, Enza Giglione, Roberta Ricotti, Gillian Elisabeth Walker, Antonella Petri, Emanuela Agosti, Giorgio Bellomo, Gianluca Aimaretti, Gianni Bona, Simonetta Bellone, Angela Amoruso, Marco Pane, Diana Di Gioia, Nicola Vitulo, Flavia Prodam. Supplementation with Bifidobacterium breve BR03 and B632 strains improved insulin sensitivity in children and adolescents with obesity in a cross-over, randomized double-blind placebo-controlled trial. Clinical Nutrition 2021; 40(7): 4585 doi: 10.1016/j.clnu.2021.06.002
|
| 20 |
Iulia Ţincu, Ioana Maria Otilia Lică, Ana Maria Daviţoiu, Sorina Chindriş, Mirela Silvia Iancu, Ioana Ghiorghiu, Doina Pleşca. Dietary supplements in the pediatric populations – friends or enemies in the liver disease?. Pediatru.ro 2021; 2(62): 14 doi: 10.26416/Pedi.62.2.2021.4887
|
| 21 |
Mina Darand, Zahra Darabi, Zahra Yari, Mehdi Hedayati, Mohammad Amin Shahrbaf, Ahmad Khoncheh, Behnam Hosseini‐Ahangar, Seyed Moayyed Alavian, Azita Hekmatdoost. The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double‐blind, placebo‐controlled clinical trial. Phytotherapy Research 2019; 33(9): 2369 doi: 10.1002/ptr.6424
|
| 22 |
Antonietta Stellavato, Anna Virginia Adriana Pirozzi, Francesca de Novellis, Ilaria Scognamiglio, Valentina Vassallo, Andrea Maria Giori, Mario De Rosa, Chiara Schiraldi. In vitro assessment of nutraceutical compounds and novel nutraceutical formulations in a liver-steatosis-based model. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0663-2
|
| 23 |
Shing-Hwa Liu, Chen-Yuan Chiu, Lin-Hui Huang, Meng-Tsan Chiang. Resistant Maltodextrin Ameliorates Altered Hepatic Lipid Homeostasis via Activation of AMP-Activated Protein Kinase in a High-Fat Diet-Fed Rat Model. Nutrients 2019; 11(2): 291 doi: 10.3390/nu11020291
|
| 24 |
Vittoria Zambon Azevedo, Valesca Dall’Alba. Fructose intake is not associated to the risk of hepatic fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD). Clinical Nutrition 2021; 40(6): 4275 doi: 10.1016/j.clnu.2021.01.022
|
| 25 |
Zeinab Mokhtari, Deanna L Gibson, Azita Hekmatdoost. Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet. Advances in Nutrition 2017; 8(2): 240 doi: 10.3945/an.116.013151
|
| 26 |
Brett R Loman, Diego Hernández-Saavedra, Ruopeng An, R Scott Rector. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutrition Reviews 2018; 76(11): 822 doi: 10.1093/nutrit/nuy031
|
| 27 |
Zeinab Mokhtari, Hossein Poustchi, Tannaz Eslamparast, Azita Hekmatdoost. Egg consumption and risk of non-alcoholic fatty liver disease. World Journal of Hepatology 2017; 9(10): 503-509 doi: 10.4254/wjh.v9.i10.503
|
| 28 |
Khadijeh Abhari, Saeede Saadati, Zahra Yari, Hedayat Hosseini, Mehdi Hedayati, Shahabeddin Abhari, Seyyed Moayyed Alavian, Azita Hekmatdoost. The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trial. Clinical Nutrition ESPEN 2020; 39: 53 doi: 10.1016/j.clnesp.2020.06.020
|
| 29 |
Sébastien Le Garf, Véronique Nègre, Rodolphe Anty, Philippe Gual. Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem. Biomedicines 2021; 9(12): 1915 doi: 10.3390/biomedicines9121915
|
| 30 |
Sahar Rafiee, Hamed Mohammadi, Abed Ghavami, Erfan Sadeghi, Zahra Safari, Gholamreza Askari. Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials. Complementary Therapies in Clinical Practice 2021; 42: 101281 doi: 10.1016/j.ctcp.2020.101281
|
| 31 |
Maria Grazia Clemente, Claudia Mandato, Marco Poeta, Pietro Vajro. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions. World Journal of Gastroenterology 2016; 22(36): 8078-8093 doi: 10.3748/wjg.v22.i36.8078
|
| 32 |
Chiara Mameli, Gian Vincenzo Zuccotti, Carla Carnovale, Erica Galli, Pilar Nannini, Davide Cervia, Cristiana Perrotta. An update on the assessment and management of metabolic syndrome, a growing medical emergency in paediatric populations. Pharmacological Research 2017; 119: 99 doi: 10.1016/j.phrs.2017.01.017
|
| 33 |
Rana K. El-Asfar, Marwa O. El-Derany, Al-Aliaa M. Sallam, Sara A. Wahdan, Ebtehal El-Demerdash, Sayed A. Sayed, Hala O. El-Mesallamy. Luteolin mitigates tamoxifen-associated fatty liver and cognitive impairment in rats by modulating beta-catenin. European Journal of Pharmacology 2021; 908: 174337 doi: 10.1016/j.ejphar.2021.174337
|
| 34 |
Yaron Ilan. Future of Treatment for Nonalcoholic Steatohepatitis: Can the Use of Safe, Evidence-Based, Clinically Proven Supplements Provide the Answer to the Unmet Need?. Digestive Diseases and Sciences 2018; 63(7): 1726 doi: 10.1007/s10620-018-5080-x
|
| 35 |
Azita Hekmatdoost, Ali Shamsipour, Mohammad Meibodi, Newsha Gheibizadeh, Tannaz Eslamparast, Hossein Poustchi. Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease. International Journal of Food Sciences and Nutrition 2016; 67(8): 1024 doi: 10.1080/09637486.2016.1210101
|
| 36 |
Reyhaneh Darvish Damavandi, Farzad Shidfar, Mohammad Najafi, Leila Janani, Mohsen Masoodi, Maryam Akbari‐Fakhrabadi, Afsaneh Dehnad. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double‐blind clinical trial. Phytotherapy Research 2021; 35(6): 3145 doi: 10.1002/ptr.6972
|
| 37 |
Fatemeh Rahimi-Sakak, Mahsa Maroofi, Hadi Emamat, Azita Hekmatdoost. Red and Processed Meat Intake in Relation to Non-Alcoholic Fatty Liver Disease Risk: Results from a Case-Control Study. Clinical Nutrition Research 2022; 11(1): 42 doi: 10.7762/cnr.2022.11.1.42
|
| 38 |
Sven Haufe, Katharina L. Hupa-Breier, Pauline Bayerle, Hedwig T. Boeck, Simone Rolff, Thorben Sundermeier, Arno Kerling, Julian Eigendorf, Momme Kück, Alexander A. Hanke, Ralf Ensslen, Lars Nachbar, Dirk Lauenstein, Dietmar Böthig, Denise Hilfiker-Kleiner, Meike Stiesch, Christoph Terkamp, Heiner Wedemeyer, Axel Haverich, Uwe Tegtbur. Telemonitoring-Supported Exercise Training in Employees With Metabolic Syndrome Improves Liver Inflammation and Fibrosis. Clinical and Translational Gastroenterology 2021; 12(6): e00371 doi: 10.14309/ctg.0000000000000371
|
| 39 |
Zahra Safari, Philippe Gérard. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cellular and Molecular Life Sciences 2019; 76(8): 1541 doi: 10.1007/s00018-019-03011-w
|
| 40 |
Fengxiang Li, Biao Xu, Samira Soltanieh, Fernando Zanghelini, Ahmed Abu-Zaid, Jian Sun. The effects of tocotrienols intake on obesity, blood pressure, inflammation, liver and glucose biomarkers: a meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition 2022; 62(26): 7154 doi: 10.1080/10408398.2021.1911926
|
| 41 |
Zohreh Sadat Sangsefidi, Faezeh Yarhosseini, Mahdieh Hosseinzadeh, Alimohammad Ranjbar, Mohsen Akhondi‐Meybodi, Hossein Fallahzadeh, Hassan Mozaffari‐Khosravi. The effect of (Cornus mas L.) fruit extract on liver function among patients with nonalcoholic fatty liver: A double‐blind randomized clinical trial. Phytotherapy Research 2021; 35(9): 5259 doi: 10.1002/ptr.7199
|
| 42 |
Parivash Shekarchizadeh-Esfahani, Fatemeh Heydarpour, Fatemeh Izadi, Cyrus Jalili. The effect of cinnamon supplementation on liver enzymes in adults: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine 2021; 58: 102699 doi: 10.1016/j.ctim.2021.102699
|